Global Genomics Services Market is valued at approximately USD 6.64 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11.0% over the forecast period 2022-2029. Genomics is the scientific field that aids in comprehending the composition, operation, and evolution of genes. Genome sequencing, identifying gene sets, examining proteins encoded by organisms, examining their relationships, and comprehending metabolic pathways are all included in genomics. The increasing government initiatives and funding, rising investment on the development of healthcare facilities, and growth of pharmaceutical & biotechnology companies for research & diagnosis are the primary factors that are propelling the market demand across the globe.
The rising prevalence of numerous chronic diseases including cancer and genetic abnormalities is witnessing the surging demand for different treatment alternatives. A genome analysis test is integrated for the early diagnosis of several ailments, including cancer and unusual genetic diseases. The effective management and treatment of the condition are attained by genome analysis, which aids doctors in determining the genetic changes and causes of the disease. The WHO estimates that in 2020, cancer accounted for approximately 10 million deaths, making it the leading cause of mortality. Also, it is estimated to reach 19.3 million new cancer cases globally by 2025. Accordingly, whole genome sequencing plays a critical role in cancer detection as it provides information about specific mutations found in cancer tissues. Additionally, it contributes to the discovery of novel cancer-related variations, including insertions, deletions, and changes in mutation rates, which, in turn, augments the market growth. Furthermore, the increasing technological advancements in the field of genomics, as well as new products and innovative services to favor the adoption of genomic sequencing are creating lucrative opportunities for the market over the forecasting years. However, the high cost required to establish a genomics laboratory and the dearth of skilled professionals are hampering the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Genomics Services Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising introduction of new genome research facilities, along with the rising adoption of various technologies for the research & diagnosis. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as changing regulatory policies for the adoption of precision medicines, as well as the increasing prevalence of cancer and other diseases among the population in the regional market.
Major market players included in this report are:
- GrandOmics
- Illumina, Inc.
- QIAGEN
- PerkinElmer Inc.
- Eurofins Scientific
- Macrogen, Inc.
- GENEWIZ
- LGC Limited
- Q2 Solutions
- Bio Rad Laboratories, Inc.
Recent Developments in the Market:
- In December 2021, BGI launched a genome sequencing platform in Belgrade in December 2021 in collaboration with the Serbian government and the Institute for Molecular Genetics and Genetic Engineering (IMGGI) in order to strengthen Serbia's reputation as a nation that invests in science and cutting-edge technology.
- In January 2021, LGC Limited announced the acquisition of Technopath Clinical Diagnostics- a company for the development and production of quality control (QC) systems and software to evaluate the accuracy of clinical lab equipment. The company's existing manufacturing capabilities for clinical genomics reference materials, viral antigens, and other products are enhanced by the acquisition.
Global Genomics Services Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Services Type, Technology, Application, End-User, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Services Type:
- Gene Expression Services (RNASeq)
- Epigenomics Services
- Genotyping
- Next-generation Sequencing
- Sanger's Sequencing
- Others
By Technology:
- Polymerase Chain Reaction (PCR)
- Next-generation Sequencing (NGS)
- Microarray
- Sanger Sequencing
- Others
By Application:
- Diagnostics
- Research
- Others
By End-User:
- Research Institutes
- Healthcare Facilities & Diagnostic Centers
- Pharmaceutical & Biotechnological Companies
- Contract Research Organization (CROs) l
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Genomics Services Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Genomics Services Market, by Services Type, 2019-2029 (USD Billion)
- 1.2.3. Genomics Services Market, by Technology, 2019-2029 (USD Billion)
- 1.2.4. Genomics Services Market, by Application, 2019-2029 (USD Billion)
- 1.2.5. Genomics Services Market, by End-User, 2019-2029 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Genomics Services Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Genomics Services Market Dynamics
- 3.1. Genomics Services Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising prevalence of numerous chronic diseases
- 3.1.1.2. Increasing government initiatives and funding
- 3.1.2. Market Challenges
- 3.1.2.1. High-cost required to establish a genomics laboratory
- 3.1.2.2. Dearth of skilled professionals
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing technological advancements in the field of genomics
- 3.1.3.2. New products and innovative services to favour the adoption of genomic sequencing
Chapter 4. Global Genomics Services Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. Industry Experts Prospective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Genomics Services Market, by Services Type
- 6.1. Market Snapshot
- 6.2. Global Genomics Services Market by Services Type, Performance - Potential Analysis
- 6.3. Global Genomics Services Market Estimates & Forecasts by Services Type 2019-2029 (USD Billion)
- 6.4. Genomics Services Market, Sub Segment Analysis
- 6.4.1. Gene Expression Services (RNASeq)
- 6.4.2. Epigenomics Services
- 6.4.3. Genotyping
- 6.4.4. Next-generation Sequencing
- 6.4.5. Sanger's Sequencing
- 6.4.6. Others
Chapter 7. Global Genomics Services Market, by Technology
- 7.1. Market Snapshot
- 7.2. Global Genomics Services Market by Technology, Performance - Potential Analysis
- 7.3. Global Genomics Services Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
- 7.4. Genomics Services Market, Sub Segment Analysis
- 7.4.1. Polymerase Chain Reaction (PCR)
- 7.4.2. Next-generation Sequencing (NGS)
- 7.4.3. Microarray
- 7.4.4. Sanger Sequencing
- 7.4.5. Others
Chapter 8. Global Genomics Services Market, by Application
- 8.1. Market Snapshot
- 8.2. Global Genomics Services Market by Application, Performance - Potential Analysis
- 8.3. Global Genomics Services Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
- 8.4. Genomics Services Market, Sub Segment Analysis
- 8.4.1. Diagnostics
- 8.4.2. Research
- 8.4.3. Others
Chapter 9. Global Genomics Services Market, by End-User
- 9.1. Market Snapshot
- 9.2. Global Genomics Services Market by End-User, Performance - Potential Analysis
- 9.3. Global Genomics Services Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
- 9.4. Genomics Services Market, Sub Segment Analysis
- 9.4.1. Research Institutes
- 9.4.2. Healthcare Facilities & Diagnostic Centers
- 9.4.3. Pharmaceutical & Biotechnological Companies
- 9.4.4. Contract Research Organization (CROs)
Chapter 10. Global Genomics Services Market, Regional Analysis
- 10.1. Genomics Services Market, Regional Market Snapshot
- 10.2. North America Genomics Services Market
- 10.2.1. U.S. Genomics Services Market
- 10.2.1.1. Services Type breakdown estimates & forecasts, 2019-2029
- 10.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
- 10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
- 10.2.1.4. End-User breakdown estimates & forecasts, 2019-2029
- 10.2.2. Canada Genomics Services Market
- 10.3. Europe Genomics Services Market Snapshot
- 10.3.1. U.K. Genomics Services Market
- 10.3.2. Germany Genomics Services Market
- 10.3.3. France Genomics Services Market
- 10.3.4. Spain Genomics Services Market
- 10.3.5. Italy Genomics Services Market
- 10.3.6. Rest of Europe Genomics Services Market
- 10.4. Asia-Pacific Genomics Services Market Snapshot
- 10.4.1. China Genomics Services Market
- 10.4.2. India Genomics Services Market
- 10.4.3. Japan Genomics Services Market
- 10.4.4. Australia Genomics Services Market
- 10.4.5. South Korea Genomics Services Market
- 10.4.6. Rest of Asia Pacific Genomics Services Market
- 10.5. Latin America Genomics Services Market Snapshot
- 10.5.1. Brazil Genomics Services Market
- 10.5.2. Mexico Genomics Services Market
- 10.5.3. Rest of Latin America Genomics Services Market
- 10.6. Rest of The World Genomics Services Market
Chapter 11. Competitive Intelligence
- 11.1. Top Market Strategies
- 11.2. Company Profiles
- 11.2.1. GrandOmics
- 11.2.1.1. Key Information
- 11.2.1.2. Overview
- 11.2.1.3. Financial (Subject to Data Availability)
- 11.2.1.4. Product Summary
- 11.2.1.5. Recent Developments
- 11.2.2. Illumina, Inc.
- 11.2.3. QIAGEN
- 11.2.4. PerkinElmer Inc.
- 11.2.5. Eurofins Scientific
- 11.2.6. Macrogen, Inc.
- 11.2.7. GENEWIZ
- 11.2.8. LGC Limited
- 11.2.9. Q2 Solutions
- 11.2.10. Bio Rad Laboratories, Inc.
Chapter 12. Research Process
- 12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
- 12.2. Research Attributes
- 12.3. Research Assumption